Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III follow-up study of GSK2186877A influenza vaccine versus Fluarix in prior participants aged 65 years or older, with Fluarix reference groups
2008-002360-33Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, single-blind trial of GSK2186877A and Fluarix in influenza (3 arms), sponsored by GSK. Primary endpoint: Solicited local and general adverse events. Started Jul 2008; status: completed.
02
Drugs
GSK2186877AFluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2008-002360-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002360-33.